Welcome to Our Parkinson's Place
I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's diseases as well and thought it would be nice to have a place where updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. This is a free site for all.
Saturday, November 21, 2015
Nov. 21, 2015
Manager Gene Kilroy says Ali can “just about walk and his speech is slurred”
After more than three decades of living with Parkinson’s disease, Muhammad Ali – widely regarded as the greatest boxer to have ever lived – is still bravely fighting the condition, according to his manager Gene Kilroy.
Ali confided to Kilroy that he felt like “a prisoner in his own body,” but that his “mind is good”.
Kilroy, who is in regular contact with the 73-year-old Ali, told the Daily Mirror: “It’s hard seeing him as he is today. He can just about walk and his speech is slurred. It takes huge effort for him to make the simplest communication now, but when he does, every word is worthwhile.”
Ali was diagnosed with Parkinson’s in 1984, three years after his retirement from boxing, a glorious career in which he won 56 of his 61 fights.
Kilroy added: “But even now he has no fear. He says, ‘I’ll stay here as long as God wants me to. When my time comes I’ll have no regrets. I have achieved a lot’.”
In December last year, he was rushed to hospital after contracting what was believed to be pneumonia. He was readmitted a few weeks later, after doctors determined he was actually suffering from a urinary tract infection.
Speaking to The Telegraph, Kilroy said: “When he got Parkinson’s and his voice wasn’t as strong as it used to be, he said, ‘Well, maybe God is punishing me for some of the things I didn’t do right. I believe that when you die and go to heaven God won’t ask you what you’ve done but what you could’ve done. Maybe I’m getting punished. He said I’m lucky, I have no pain with this Parkinson’s. I’m a prisoner in my own body but I don’t have any pain. My mind is good. My speech maybe slurred but my mind is good’.”
by Geoffrey Chang
Friday, November 20, 2015
Thursday, November 19, 2015
Nov. 20, 2015
Researchers from Imperial College London and Newcastle University believe they have found a potential new way to target cells of the brain affected by Parkinson’s disease.
The new technique is relatively non-invasive and has worked to improve symptoms of the disease in rats.
Parkinson’s disease causes progressive problems with movement, posture and balance. It is currently treated with drugs, but these have severe side-effects and can become ineffective after around five years. The only treatment subsequently available to patients is deep brain stimulation, a surgical technique where an electrical current is used to stimulate nerve cells in the brain.
As well as being an invasive treatment, it has mixed results — some patients benefit while others experience no improvement or even deteriorate. Researchers believe this is because the treatment is imprecise, stimulating all types of nerve cells, not just the intended target.
The new study, published in the journal Molecular Neurodegeneration, examined a less invasive and more precise alternative, designed to target and stimulate a particular type of nerve cell called cholinergic neurons. These are found within a part of the brain called the pedunculopontine nucleus, or PPN.
“If you were to peer inside the PPN, it is like a jungle with a massive variety of nerve cells that behave differently and have different jobs to do,” said Dr Ilse Pienaar, Honorary Lecturer in Neuroscience at Imperial College London.
Scientists already suspect that cholinergic neuron cells are involved in Parkinson’s disease. This is because in post mortem studies of patients’ brains, about half of these cells have perished, for reasons that are currently unknown.
Nov. 18, 2015
Short-term exercise interventions have been shown to benefit health and wellbeing and reduce motor and non motor symptoms in the short term in people with Parkinson’s disease (PD). Exercise over a longer period of time may reduce the impact of disability for people with PD but the effect of longer-term exercise has not been established. People with PD tend to have low activity levels and reduce their physical activity over time. To achieve an ongoing active lifestyle people with PD will need to be able to use community facilities. However, people with PD report feeling deterred from using community exercise schemes. As such it is unsurprising that people with PD are observed to have low levels of physical activity and participation in exercise despite expressing a desire to be active. With the help of fitness professionals, people with PD and NHS clinicians we have developed a community exercise programme for people with PD.
We propose to study: People with Parkinson’s disease who are able to walk 100m How we would undertake the investigation: Participants will be recruited from neurology services in Oxfordshire and Reading. We will randomly assign participants into one of two groups –a community exercise programme group or to a comparison control group who will perform a hand writing programme. The exercise programme will be supported from current PD NHS services and delivered in community fitness centres and gyms by a fitness professional supported by a physiotherapist and patient information materials. How we would evaluate the study: Recruited patients will be monitored at entry to the study and at three, six, and twelve months. We will evaluate the effect of the exercise programme on PD motor and non motorsymptoms, fitness, health and wellbeing. We will ask participants their views on the process and service. Expected outcome: We will determine the effect of exercising for a longer period of time and if further investigations are needed.